Clinical Progress in Mesenchymal Stem Cell Therapy: A Focus on Rheumatic Diseases

Documenti analoghi

• Enhanced Colon Regeneration in Ulcerative Colitis via Mesenchymal Stem Cell Medium and 17‐β Estradiol
  di: Zahra Bakhtiary, et al.
  Pubblicazione: (2026)
• The Improvement of Experimentally Induced Gastric Ulcers in Rats by Inhibiting Vascularization Through the Blocking of the TNF‐α Type 1 Receptor
  di: Abdullah Alattar, et al.
  Pubblicazione: (2025)
• The Exosomes Derived From Bone Marrow Mesenchymal Stem Cells Alleviate Inflammatory Injury in Heart Failure Disease by Enhancing the Expression of KLF4
  di: Yutong Han, et al.
  Pubblicazione: (2025)
• Tacrolimus Trough Concentration‐Escalating Bipartite Therapy (Glucocorticoids Combined With Tacrolimus) for Refractory MDA5 Antibody‐Positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Pneumonia
  di: Anji Xiong, et al.
  Pubblicazione: (2025)
• Human Umbilical Cord Mesenchymal Stem Cells Modulate Cytokine Secretion of CD4+ T Cell in Systemic Lupus Erythematosus by Inhibiting HSP90AA1 in the Glucose‐Activated PI3K‐AKT Pathway
  di: Lu Jin, et al.
  Pubblicazione: (2025)